AZN vs EUDAW · P/E 28, $288.38B cap vs rev $9.8M
AstraZeneca PLC (AZN) versus EUDA Health Holdings Limited (EUDAW) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
EUDA Health Holdings Limited (EUDAW) common stock listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported EUDAW revenue for 2022-12-31 was $9.8M. Net income was -$24.9M. Revenue was down 6.7% from 2021-12-31 to 2022-12-31. EUDAW currently screens at market cap $0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. EUDAW currently screens at market cap $0.
Not investment advice. Open the AZN and EUDAW stock pages for the full models.
Not investment advice.